Amedisys, Inc.

NAS:AMEDHealthcare

——At close · Market cap —

USD billions	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	YoY
Revenue	2.0	2.1	2.2	2.2	2.2	2.3	+5.0%
Cost of revenue	1.2	1.2	1.2	1.3	1.2	1.3	+6.8%
Gross profit	0.8	0.9	1.0	1.0	1.0	1.0	+2.7%
Research & development	0.0	0.0	0.0	0.0	0.0	0.0	−100.0%
Selling, general & administrative	0.6	0.7	0.7	0.8	0.8	0.8	+1.3%
Selling & marketing	0.0	0.0	0.0	0.0	0.5	0.0	−100.0%
Operating expenses	0.6	0.7	0.7	0.8	0.8	0.9	+10.6%
Operating income	0.2	0.2	0.3	0.2	0.2	0.1	−39.6%
Interest expense	0.0	0.0	0.0	0.0	0.0	0.0	−1.6%
Interest income	0.0	0.0	0.0	0.0	0.0	0.0	+148.0%
Other income / expense	(0.0)	(0.0)	0.0	(0.0)	(0.1)	(0.0)	+92.9%
Pre-tax income	0.2	0.2	0.3	0.2	0.0	0.1	+117.6%
Income tax	0.0	0.0	0.1	0.0	0.1	0.0	−5.0%
Net income	0.1	0.2	0.2	0.1	(0.0)	0.0	+543.5%
Discontinued operations	0.0	0.0	0.0	0.0	0.0	0.0	—
Other net income adjustments	0.0	0.0	0.0	0.0	0.0	0.0	—
EPS, basic (per share)	3.95	5.64	6.41	3.65	(0.30)	1.32	+540.0%
EPS, diluted (per share)	3.84	5.52	6.34	3.63	(0.30)	1.31	+536.7%
EBITDA	0.2	0.3	0.3	0.2	0.2	0.1	−66.1%
Depreciation & amortization	0.0	0.0	0.0	0.0	0.0	0.0	−24.5%
Weighted average shares (shares)	32,142,000	32,558,999	32,642,000	32,517,000	32,490,000	32,718,000	+0.7%
Weighted average diluted shares (shares)	32,990,000	33,268,000	32,972,000	32,653,000	32,598,999	33,051,000	+1.4%
Gross margin	41.2%	42.8%	44.3%	43.3%	44.3%	43.3%	−1.0 pts
Operating margin	9.1%	10.6%	11.4%	8.1%	7.0%	4.0%	−3.0 pts
Net margin	6.5%	8.9%	9.4%	5.3%	−0.4%	1.8%	+2.3 pts

USD billionsUpdated 24 Apr 2025 ·

ⓘ

Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.